Vireo Growth (VREOF) Interest & Investment Income (2025)

Vireo Growth (VREOF) reported Interest & Investment Income of $5.6 million for Q4 2025, up 33183.43% sequentially from $16707.0 in Q2 2025.

Vireo Growth (VREOF) Interest & Investment Income (2025) Analysis & Trends

Vireo Growth (VREOF) has 1 years of Interest & Investment Income data on file, last reported at $5.6 million in Q4 2025.

For the quarter ending Q4 2025, Interest & Investment Income changed N/A year-over-year to $5.6 million; the trailing twelve-month figure through Dec 2025 stood at $5.7 million (changed N/A YoY), and the FY2025 full-year result was $5.7 million, up 6252.22% from the prior year.
Interest & Investment Income improved to $5.6 million in Q4 2025, from $16707.0 in the prior quarter.
In the past five years, Interest & Investment Income ranged from a high of $5.6 million in Q4 2025 to a low of $16707.0 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Int & Inv Inc (Qtr)
1	Haleon	88.07 Bn	86.20 Bn	-	-
2	Teva Pharmaceutical Industries	35.75 Bn	32.01 Bn	1.97 Bn	-
3	Zoetis	31.84 Bn	29.90 Bn	1.62 Bn	-
4	Takeda Pharmaceutical	27.18 Bn	23.12 Bn	4.39 Bn	32.85 Mn
5	United Therapeutics	23.09 Bn	20.93 Bn	648.10 Mn	41.80 Mn
6	RedHill Biopharma	21.32 Bn	21.32 Bn	-	-
7	Viatris	19.96 Bn	18.16 Bn	1.16 Bn	-
8	Neurocrine Biosciences	17.66 Bn	16.34 Bn	800.70 Mn	28.10 Mn
9	Elanco Animal Health	12.44 Bn	12.02 Bn	785.00 Mn	-
10	Vireo Growth	10.53 Bn	10.38 Bn	59.30 Mn	-

Download Data